Security National Trust’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-375
Closed 489
2019
Q4
$0 Hold
375
﹤0.01% 446
2019
Q3
$0 Hold
375
﹤0.01% 375
2019
Q2
$0 Hold
375
﹤0.01% 383
2019
Q1
$0 Hold
375
﹤0.01% 389
2018
Q4
$0 Hold
375
﹤0.01% 390
2018
Q3
$0 Hold
375
﹤0.01% 398
2018
Q2
$0 Hold
375
﹤0.01% 400
2018
Q1
$0 Hold
375
﹤0.01% 409
2017
Q4
$0 Hold
375
﹤0.01% 404
2017
Q3
$0 Hold
375
﹤0.01% 427
2017
Q2
$0 Hold
375
﹤0.01% 436
2017
Q1
$0 Hold
375
﹤0.01% 448
2016
Q4
$0 Hold
375
﹤0.01% 469
2016
Q3
$0 Hold
375
﹤0.01% 480
2016
Q2
$0 Hold
375
﹤0.01% 481
2016
Q1
$0 Hold
375
﹤0.01% 505
2015
Q4
$0 Hold
375
﹤0.01% 511
2015
Q3
$0 Hold
375
﹤0.01% 498
2015
Q2
$0 Hold
375
﹤0.01% 486
2015
Q1
$0 Hold
375
﹤0.01% 533
2014
Q4
$0 Hold
375
﹤0.01% 545
2014
Q3
$0 Hold
375
﹤0.01% 563
2014
Q2
$0 Hold
375
﹤0.01% 554
2014
Q1
$0 Hold
375
﹤0.01% 553
2013
Q4
$0 Hold
375
﹤0.01% 569
2013
Q3
$1K Hold
375
﹤0.01% 529
2013
Q2
$1K Buy
+375
New +$659 ﹤0.01% 499

Security National Trust's GCVRZ Position: Q1 2020 in Review

Security National Trust sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 375 shares.

Security National Trust first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $1K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Security National Trust reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Security National Trust sold 375 Sanofi Contingent Value Rights shares in Q1 2020.
  • Security National Trust first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
  • Security National Trust's Sanofi Contingent Value Rights position peaked at $1K in Q3 2013.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Security National Trust's 13F filing for Q1 2020, filed 11 May 2020.